Fidelity Investments’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3 Hold
1
﹤0.01% 5397
2025
Q4
$4 Buy
+1
New +$4 ﹤0.01% 5393
2025
Q3
Sell
-38
Closed -$401 5479
2025
Q2
$401 Sell
38
-29
-43% -$396 ﹤0.01% 5051
2025
Q1
$920 Buy
+67
New +$802 ﹤0.01% 4965
2024
Q2
Sell
-11
Closed -$238 5506
2024
Q1
$238 Buy
+11
New +$105 ﹤0.01% 4908
2023
Q4
Hold
0
5380
2023
Q3
Hold
0
5214
2023
Q1
Sell
-10
Closed -$180 5406
2022
Q4
$180 Hold
10
﹤0.01% 4837
2022
Q3
$0 Hold
10
﹤0.01% 5154
2022
Q2
$0 Buy
+10
New +$366 ﹤0.01% 5212
2021
Q4
Sell
-8
Closed -$1K 4654
2021
Q3
$1K Buy
8
+6
+300% +$1.25K ﹤0.01% 4150
2021
Q2
$1K Hold
2
﹤0.01% 4048
2021
Q1
$1K Buy
+2
New +$672 ﹤0.01% 3841

Other funds holding IMNN

Fidelity Investments's IMNN Position: Q1 2026 in Review

Fidelity Investments held its Imunon (IMNN) position steady in Q1 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #5397.

Fidelity Investments first reported a position in IMNN in Q1 2021 and has held it in 11 quarters since. The position peaked at $1K in Q3 2021. 19 funds tracked by Wall St. Rank hold IMNN as of Q1 2026.

  • Fidelity Investments held 1 share of Imunon worth $3 as of Q1 2026.
  • Fidelity Investments left its Imunon share count unchanged in Q1 2026.
  • Imunon made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5397 holding.
  • Fidelity Investments first reported a position in Imunon in Q1 2021 and has held it in 11 quarters since.
  • Fidelity Investments's Imunon position peaked at $1K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Imunon as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.